500087:BOM
Cipla Ltd
₹1,325.30
arrow_upward
+0.95%(+12.45) 1D
Okt 15, 9:46:04 AM GMT+5:30 · INR
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa 500087...
Buksan
₹1,314.60
Mataas
₹1,329.20
Mababa
₹1,311.20
Mkt. cap
1.07T
Avg. na dami
37.03K
Dami
10.50K
Dividend
0.98%
Bawat tatlong buwang dividend
₹3.25
Petsa ng ex-dividend
Hun 5, 2026
P/E ratio
31.78
Mataas nang 52-wk
₹1,672.20
Mababa nang 52-wk
₹1,165.55
EPS
₹41.70
Mga natitirang share
805.67M
Bilang ng mga empleyado
31K
Buksan
₹1,314.60
Mataas
₹1,329.20
Mababa
₹1,311.20
Mkt. cap
1.07T
Avg. na dami
37.03K
Dami
10.50K
Dividend
0.98%
Bawat tatlong buwang dividend
₹3.25
Petsa ng ex-dividend
Hun 5, 2026
P/E ratio
31.78
Mataas nang 52-wk
₹1,672.20
Mababa nang 52-wk
₹1,165.55
EPS
₹41.70
Mga natitirang share
805.67M
Bilang ng mga empleyado
31K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
investingLive
·
10 oras ang nakalipas
S&P 500 decline extends to 100 points with tech hit particularly hard
Bloomberg.com
·
7 oras ang nakalipas
S&P 500 Ends Longest Streak of Calm Since 2020 as AI Trade Sinks
MarketWatch
·
1 buwan ang nakalipas
The S&P 500 keeps climbing on days when stocks broadly struggle. Here’s what’s going on.
Reuters
·
1 buwan ang nakalipas
S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
Profile
Cipla Limited is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, paediatric and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia
Tungkol sa Cipla Ltd
CEOUmang Vohra
Mga Empleyado31.4K
Itinatag1935
HeadquartersMumbai, Maharashtra, India
Sektor-
Websitecipla.com